- Trials with a EudraCT protocol (116)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
116 result(s) found for: Team physician.
Displaying page 1 of 6.
EudraCT Number: 2006-004927-12 | Sponsor Protocol Number: 06-09-2006-0208-296-2401 | Start Date*: 2009-11-20 |
Sponsor Name:St Helier Hospital NHS Trust | ||
Full Title: A double-blind randomised placebo controlled study of cotrimoxazole in the treatment of advanced pulmonary fibrosis | ||
Medical condition: Advanced pulmonary fibrosis including common subtypes of usual interstitial pneumonitis and fibrotic non specific pneumonitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: View results |
EudraCT Number: 2021-001174-29 | Sponsor Protocol Number: 77040 | Start Date*: 2021-05-31 |
Sponsor Name:Amsterdam UMC | ||
Full Title: Effectiveness of methylphenidate in adults with phenylketonuria and attention-deficit/hyperactivity disorder: An N-of-1 series | ||
Medical condition: Phenylketonuria, ADHD | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-004053-76 | Sponsor Protocol Number: NL73102.018.20 | Start Date*: 2020-12-10 |
Sponsor Name:Amsterdam UMC [...] | ||
Full Title: Effectiveness of methylphenidate in children and adults with Smith Magenis syndrome and attention-deficit/hyperactivity disorder: An N-of-1 series | ||
Medical condition: Smith Magenis syndrome | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-004263-84 | Sponsor Protocol Number: CHUBX2017/29 | Start Date*: 2021-02-24 |
Sponsor Name:CHU de Bordeaux | ||
Full Title: AntiPlatelet theraPy stratEgy followiNg left atrial appenDAGe closurE | ||
Medical condition: Atrial Fibrillation, atrial appendage, anticoagulants, stroke, platelet aggregation inhibitors | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2010-023802-10 | Sponsor Protocol Number: B1801023 | Start Date*: 2011-07-29 | |||||||||||
Sponsor Name:Pfizer Inc.235 East 42nd Street, New York, NY 10017 | |||||||||||||
Full Title: AN OPEN LABEL EXTENSION STUDY TO ASSESS THE LONG TERM SAFETY OF ETANERCEPT IN CHILDREN AND ADOLESCENTS WITH EXTENDED OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS, ENTHESITIS RELATED ARTHRITIS, OR P... | |||||||||||||
Medical condition: OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS, ENTHESITIS RELATED ARTHRITIS, OR PSORIATIC ARTHRITIS | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) BE (Completed) FR (Completed) LT (Completed) SK (Completed) CZ (Completed) SI (Completed) ES (Completed) DE (Completed) LV (Completed) PL (Completed) NL (Completed) Outside EU/EEA NO (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-003284-62 | Sponsor Protocol Number: 012508 | Start Date*: 2019-07-18 |
Sponsor Name:Queen Mary University London | ||
Full Title: A randomised, blinded, placebo controlled, Phase 2a study to evaluate the safety and efficacy of administering Regadenoson to patients with critical injury and signs of haemorrhagic shock | ||
Medical condition: Cardiovascular collapse following traumatic haemorrhage | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2021-000134-34 | Sponsor Protocol Number: TEAM(B115UCS2019) | Start Date*: 2021-05-24 | |||||||||||
Sponsor Name:ENTE OSPEDALIERO OSPEDALI GALLIERA | |||||||||||||
Full Title: Time restricted Eating And Metformin (TEAM) in invasive breast cancer (IBC) or ductal carcinoma in situ (DCIS). A randomized, phase IIb, window of opportunity presurgical trial. | |||||||||||||
Medical condition: Luminal (ER+ve and/or PgR+ve >=1%) invasive breast cancer not candidate to neo - adjuvant chemotherapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-005158-12 | Sponsor Protocol Number: NCT-2017-0530 | Start Date*: 2019-04-01 |
Sponsor Name: Ruprecht-Karls-University Heidelberg Medical Faculty, University Hospital | ||
Full Title: TEAM-Trial: Targeting Epigenetic therapy resistance in AML with Bortezomib: A multi-centre matched threshold crossing phase II approach | ||
Medical condition: Patients with confirmed diagnosis of Acute Myeloid Leukemia (AML)according to WHO-2016 classification (except acute promyelocytic leukemia) either de novo AML, AML after preceding myelodysplastic o... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-003853-13 | Sponsor Protocol Number: HPEPA-01 | Start Date*: 2005-01-13 |
Sponsor Name:Hela Pharma AB | ||
Full Title: Placebo controlled, randomised, double-blind, multicentre study of PlusEPA (a PUFA, Polyunsaturated Fatty Acids, supplement) as treatment for ADHD (combined type) with co-morbidity in Swedish child... | ||
Medical condition: ADHD (combined type) and co-morbidity in children | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-004148-31 | Sponsor Protocol Number: PREDMETH_NL71782.078.19 | Start Date*: 2020-02-26 |
Sponsor Name:Erasmus Medisch Centrum Dept. of Pulmonology | ||
Full Title: The PREDMETH trial: Effectiveness of methotrexate versus prednisone as first-line therapy for pulmonary sarcoidosis – A randomized controlled trial | ||
Medical condition: pulmonary sarcoidosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2015-000962-76 | Sponsor Protocol Number: 17992 | Start Date*: 2015-09-22 | |||||||||||
Sponsor Name:Bayer AG | |||||||||||||
Full Title: Single-dose study testing a rivaroxaban granules for oral suspension formulation in children from 2 months to 12 years with previous thrombosis | |||||||||||||
Medical condition: Thrombosis | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) BE (Completed) IE (Completed) ES (Completed) FI (Completed) HU (Completed) SE (Completed) FR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012769-74 | Sponsor Protocol Number: A4021040 | Start Date*: 2009-09-02 | |||||||||||
Sponsor Name:Pfizer Inc., 235 East 42nd Street, New York, NY 110017 | |||||||||||||
Full Title: PHASE 1 SAFETY AND TOLERABILITY STUDY OF FIGITUMUMAB COMBINED WITH PEGVISOMANT IN PATIENTS WITH ADVANCED SOLID TUMORS | |||||||||||||
Medical condition: Advanced Solid Tumors | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-000837-17 | Sponsor Protocol Number: NL80854.018.22 | Start Date*: 2022-12-07 |
Sponsor Name:Amsterdam UMC | ||
Full Title: Subcutaneous vedolizumab drug de-escalation using therapeutic drug monitoring in inflammatory bowel disease: a randomized controlled pilot study | ||
Medical condition: Inflammatory bowel diseases (Crohn's disease, ulcerative colitis) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004198-28 | Sponsor Protocol Number: BAY1000394/14615 | Start Date*: 2014-06-18 |
Sponsor Name:Bayer AG | ||
Full Title: A randomized, double blind, placebo-controlled, multicenter phase II study to evaluate efficacy and safety of roniciclib in subjects with extensive-stage disease small cell lung cancer (SCLC) who a... | ||
Medical condition: extensive-stage disease small cell lung cancer (ED SCLC) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) BE (Completed) HU (Completed) IT (Completed) PL (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2010-019888-10 | Sponsor Protocol Number: B1531002 | Start Date*: 2010-11-10 | |||||||||||
Sponsor Name:Pfizer Inc., 235 East 42nd Street, New York, NY 10017 | |||||||||||||
Full Title: PROSPECTIVE OPEN-LABEL INVESTIGATION OF THE NON-SURGICAL TREATMENT WITH COLLAGENASE CLOSTRIDIUM HISTOLYTICUM (XIAPEX®) | |||||||||||||
Medical condition: Dupuytren’s contracture | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) HU (Completed) ES (Completed) SE (Completed) DK (Completed) DE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004138-13 | Sponsor Protocol Number: 4976 | Start Date*: 2019-10-16 | |||||||||||
Sponsor Name:THE ROYAL MARSDEN NHS FOUNDATION | |||||||||||||
Full Title: A multicentre phase II non-randomised trial assessing the efficacy of DKN-01 plus atezolizumab in patients with advanced mismatch repair proficient oesophagogastric cancer | |||||||||||||
Medical condition: Patients with advanced mismatch repair proficient oesophagogastric cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002534-16 | Sponsor Protocol Number: FSJD-INNOVA-2020 | Start Date*: 2021-10-15 | |||||||||||
Sponsor Name:Fundació Sant Joan de Déu | |||||||||||||
Full Title: 12-month randomized, double-blind, placebo-controlled, pharmacological clinical trial to evaluate the effectiveness, cost-utility and neurobiological effects of low-dose Naltrexone in patients with... | |||||||||||||
Medical condition: Fibromyalgia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004002-15 | Sponsor Protocol Number: KETOP_L_03102 | Start Date*: 2014-12-19 | |||||||||||
Sponsor Name:Sanofi | |||||||||||||
Full Title: Local, Phase IV, Multicenter, Double-blind, Randomized, Parallel, With Two Treatment Arms, Placebo-controlled Study to Evaluate the Reduction of Inflammatory Symptoms in the Treatment of Bacterial ... | |||||||||||||
Medical condition: Pharyngotonsillitis | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002867-13 | Sponsor Protocol Number: POP6135,HMR3647B/3005 | Start Date*: 2015-03-17 | |||||||||||
Sponsor Name:Sanofi-aventis | |||||||||||||
Full Title: Multinational, randomized, double blind, double dummy, pharmacokinetic study of telithromycin oral suspension (25 mg/kg once daily for 7-10 days), with secondary assessments of safety relative to a... | |||||||||||||
Medical condition: Community acquired pneumonia | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004064-35 | Sponsor Protocol Number: | Start Date*: 2018-04-17 |
Sponsor Name:Southern Health NHS Foundation Trust | ||
Full Title: Liraglutide and the management of overweight and obesity in people with schizophrenia: a pilot study | ||
Medical condition: Schizophrenia, schizoaffective disorder or first episode psychosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
